Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level). Making data-driven decisions on how to fight the COVID-19 pandemic without completely shutting down economies will require […]
Click here to view original web page at immunology.sciencemag.org
